drugset / Trial / NCT01448720
Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to explore the efficacy of paliperidone palmitate administered as a once monthly injection in patients with an acute exacerbation of schizophrenia.
Timeline
- Start
- 2011-09
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | paliperidone palmitate | Unknown | 75 mg | Intramuscular |